Journals / Hacettepe Journal of Biology and Chemistry / 2020 / Cilt: 48 - Sayı: 4

Designing of alternative polymeric nano-chelator for treatment in acute iron poisoning by molecular imprinting approach

Pages
319–331
Publication Date
2020-07-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Fe3+ removal studies were performed in both aqueous solution and intestinal mimicking solution.The results indicate that Fe3+ imprinted poly(HEMA-MAGA) nanoparticles is an alternative chelating agent for the selective Fe3+ ions removal with a short time and very high capacity.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of this study is to develop an alternative polymeric chelating agent for rapid and selectively removal with high capacity of Fe3+ ions from the gastrointestinal tract for the oral treatment of acute iron poisoning.
📊
Key Findings & Data:For this purpose, Fe3+ imprinted poly(hydroxyethyl methacrylate-N-methacryloyl-(l)- glutamic acid) (HEMA-MAGA) nanoparticles synthesized by surfactant free emülsiyon polymerization.
💡
Conclusion & Impact:Fe3+ removal studies were performed in both aqueous solution and intestinal mimicking solution.The results indicate that Fe3+ imprinted poly(HEMA-MAGA) nanoparticles is an alternative chelating agent for the selective Fe3+ ions removal with a short time and very high capacity.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Acute iron poisoning · Iron removal · Molecularly Imprinted Polymers (MIP)

Abstract

The aim of this study is to develop an alternative polymeric chelating agent for rapid and selectively removal with high capacity of Fe3+ ions from the gastrointestinal tract for the oral treatment of acute iron poisoning. For this purpose, Fe3+ imprinted poly(hydroxyethyl methacrylate-N-methacryloyl-(l)- glutamic acid) (HEMA-MAGA) nanoparticles synthesized by surfactant free emülsiyon polymerization. Molecular imprinting (MIP) technique is used to enhance the selectivity of nanoparticles. Due to being carboxyl and amide groups on the MAGA monomer, it was chosen as a chelating agent for Fe3+ ions. Before the synthesizing of Fe3+ imprinted polymer, Fe3+ ions were complexed with MAGA and then Fe3+ imprinted nanoparticles were synthesized in the presence of this Fe3+-MAGA complexes. Poly(HEMA-MAGA) nanoparticles were characterized by infrared spectroscopy (FTIR), atomic force microscopy (AFM). Average particle size and size distribution also determined by Zeta sizer. The specific surface area and mead diameter of the Fe3+ imprinted poly(HEMA-MAGA) nanoparticles was 895 m2.g-1 and 95.3 nm, respectively. The maximum Fe3+ ions binding capacity of the poly(HEMA-MAGA) nanoparticles at pH:4.0 were 206.4 mg.g-1 nanoparticles. Fe3+ removal performance of the Fe3+ imprinted poly(HEMA-MAGA) nanoparticles with presence of other ions, optimum medium pH, temperature and equilibrium binding time were also investigated. Fe3+ removal studies were performed in both aqueous solution and intestinal mimicking solution.The results indicate that Fe3+ imprinted poly(HEMA-MAGA) nanoparticles is an alternative chelating agent for the selective Fe3+ ions removal with a short time and very high capacity.

🔖

Cite This Article

KARAKOÇ, V. (2020). Designing of alternative polymeric nano-chelator for treatment in acute iron poisoning by molecular imprinting approach. Hacettepe Journal of Biology and Chemistry, Cilt: 48 - Sayı: 4, 319–331. https://ajindex.com/articles/255704

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. G. Papanikolaoua, K. Pantopoulos, Iron metabolism and toxicity, Toxicol. Appl. Pharmacol., 202 (2005) 199- 211
  2. J. Wang, K. Pantopoulos, Regulation of cellular iron metabolism, Biochem. J., 434 (2011) 365-381
  3. Lindsay H. Allen, Iron Supplements: Scientific Issues Concerning Efficacy and Implications for Research and Programs, J. Nutr., 132 (2002) 813-819
  4. Jeffrey S. Fine, Iron Poisoning, Curr. Probl. Pediatr. and Adolescent Health Care 30, 3 (2000) 71-90. • 5. Britton RS, Leicester KL, Bacon BR. Iron toxicity and chelation therapy. Int J Hematol. 76 (2002) 219-228
  5. Crisponi G, Remelli M., Iron chelating agents for the treatment of iron overload., Coord Chem Rev., 252 (2008) 1225-1240
  6. H. Heli, S. Mirtorabi, K. Karimian, Advances in iron chelation: an update, Expert Opin. Ther. Patents., 21 (2011) 819 -856
  7. D. R. Rıchardson And P. Ponka, Pyridoxal isonicotinoyl hydrazone and its analogs: Potential orally effective iron-chelating agents for the treatment of iron overload disease. J Lab Clin Med., 131 (1998) 306-316
  8. JB Mowry, DA Spyker, DE Brooks, A Zimmerman, JL Schauben. 2015 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 33rd Ann. Rep. Clin Toxicol (Phila). 54 (2016) 924-1109
  9. J. R. Mahoney, Jr., P. E. Hallaway, B. E. Hedlund, J. W. Eaton, Acute Iron Poisoning Rescue with Macromolecular Chelators, J Clin Invest. 84 (1989)1362 -1366
  10. M. Berkovitch, A. Livne, G. Lushkov, M. Segal, C. Talmor, Y. Bentur, J. Klein, G. Koren, The efficacy of oral deferiprone in acute iron poisoning, Am. J. Emerg Med., 18 (2000) 36-40
  11. M Yassin, AT Soliman, V De Sanctis, A young adult with unintended acute intravenous iron intoxication treated with oral chelation: The use of liver ferriscan for diagnosing and monitoring tissue iron load. Mediterr J Hematol Infect Dis. 9 (2017) 1-6
  12. H Halil, N Tuygun, E. Polat, C. Demir Karacan, Minimum ingested iron cut-off triggering serious iron toxicity in children. Pediatrics International 61 (2019) 444- 448
  13. H.F Gomez, H. H Mc Clafferty, D. Flory, J. Brent, R. C Dart, Prevention of Gastrointestinal Iron Absorption by Chelation From an Orally Administered Premixed Deferoxamine/Charcoal Slurry. Ann. Emerg. Med., 30 (1997) 587-592
  14. Zu D. Liu, Robert C. Hider, Design of Clinically Useful Iron(III)-Selective Chelators. Med Res Rev., 22 (2002) 26- 64 16. D. Y Liu, Z. DLiu, R. C Hider, Oral iron chelators - development and application,